CorMedix
CRMD
40 hedge funds and large institutions have $34.8M invested in CorMedix in 2019 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 16 closing their positions.
220% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 5
68% more capital invested
Capital invested by funds: $20.7M → $34.8M (+$14.1M)
12.43% more ownership
Funds ownership: 3.04% → 15.47% (+12%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 16
2% less funds holding
Funds holding: 41 → 40 (-1)
36% less call options, than puts
Call options by funds: $6.37M | Put options by funds: $9.96M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.03M |
| 2 |
Goldman Sachs
New York
|
+$1.11M |
| 3 |
EGI
EAM Global Investors
Solana Beach,
California
|
+$896K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$844K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$617K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
-$2.13M |
| 2 |
BlackRock
New York
|
-$989K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$141K |
| 4 |
PD
Planning Directions
Glen Mills,
Pennsylvania
|
-$139K |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$77K |
CRMD Hedge Fund Activity: Q1 2019 in Review
40 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q1 2019, worth a combined $34.8M — up 68% from $20.7M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of CRMD and 15 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 16 added.
The largest buyer was Millennium Management, adding an estimated $2.03M. The largest seller was Cresset Asset Management, exiting entirely with an estimated $2.13M sold.
- 40 institutional investors held CorMedix (CRMD) as of Q1 2019, down from 41 in Q4 2018.
- Funds reported $34.8M of CorMedix stock for Q1 2019, up 68% quarter-over-quarter.
- 15 funds opened new CorMedix positions in Q1 2019 and 16 closed out, a net change of -1 holder.
- The largest CorMedix buyer in Q1 2019 was Millennium Management, an estimated $2.03M added.
- The largest CorMedix seller in Q1 2019 was Cresset Asset Management, an estimated $2.13M sold.
Based on aggregated 13F filings for Q1 2019.